Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
4.53M
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
455K
-
Shares change
-
-295K
-
Total reported value, excl. options
-
$273K
-
Value change
-
-$1.16M
-
Number of buys
-
8
-
Number of sells
-
-7
-
Price
-
$0.60
Significant Holders of PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM) as of Q1 2025
15 filings reported holding PBM - PSYENCE BIOMEDICAL LTD. - Common Shares, without par value as of Q1 2025.
PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 455K shares
of 4.53M outstanding shares and own 10.05% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (257K shares), CITADEL ADVISORS LLC (75.3K shares), Virtu Financial LLC (36.5K shares), AdvisorShares Investments LLC (35.5K shares), UBS Group AG (33.6K shares), TWO SIGMA SECURITIES, LLC (12.9K shares), Stonehage Fleming Financial Services Holdings Ltd (4.48K shares), MORGAN STANLEY (69 shares), Scientech Research LLC (0 shares), and Essential Planning, LLC. (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.